Tanda was established in September 2019, with it's registered address at Building B1, Innovation Park, Optics Valley Bio-City, No. 666 Gaoxin Avenue, East Lake Development Zone, Wuhan, Hubei Province. It is a high-tech biotechnology enterprise founded by senior neurobiology experts and overseas returnees.

The company's research focuses primarily on the health sector, including the development of diagnostic reagents for early detection of Alzheimer's disease, the establishment of non-transgenic sporadic AD animal models, the screening of therapeutic drugs targeting key molecular targets of AD, and the industrial production and technological R&D of health products such as dietary supplements or functional foods, drug intermediates, natural medicines, and chemical drugs aimed at improving Alzheimer's symptoms. Additionally, the company provides contract manufacturing services, technology transfer, and promotion for other related bioproducts such as neural stem cell therapy.

Currently, the company has established a novel bioreactor antigen/antibody production platform, a genetically engineered protein antibody platform, a point mutation antibody production platform, an immunodiagnostic reagent development and testing platform, a serum-free neuronal differentiation platform, a transgenic and non-transgenic animal model establishment platform, a drug screening platform, and a health functional food development platform. The establishment of these platforms provides technical support and solutions for the early detection, intervention, and treatment of Alzheimer's disease.